INSIGHTS ON DRUG DEVELOPMENT

• Viral Gene Therapy: Reducing Costs To Improve Patient Access

  Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.

• How Isogenic Organ-Chips Are Transforming The Future Of Research

  Modeling the human brain requires more than simplified systems. New approaches that incorporate diverse cell types are improving how researchers study neurovascular function with greater precision.

• UPLC-MS/MS Determination Of GLP-1 Analogue

  Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.

• Ask Us Anything: Matthew Schiesher On Validation During Tech Transfer

  Matthew Schiesher, Head of R&D at Cambrex Charles City, on validating processes under the clock — and how running multiple sites in parallel shortens the path to launch when patients are waiting.

• Closing The QC Gap For mAbs: Rapid Answers Without Compromising

  6/9/2026

  Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.

• Five Practical Considerations To Move From Concept To Clinic

  12/17/2025

  Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

• Enabling Quality By Design

  9/8/2025

  Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.

• Deciphering Nanoparticle Properties With AF4

  5/6/2026

  Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.

• Seed Train Intensification Using High Cell Density Cryopreservation

  8/11/2025

  Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.